This IDC TechBrief deals with the use of robotic process automation across the life science industry life cycle. As the industry regularly seeks to improve operational effectiveness, RPA offers the potential to automate repetitive manual processes, freeing up resources to focus on more pressing issues. The opportunity for RPA is expected to expand as RPA expands beyond individual processes to broader platforms and as organizational best practices, machine learning, and other AI technologies become embedded within RPA solutions. As part of the broader spectrum of AI technologies, the adoption of RPA is an incremental step in leveraging technology to fundamentally transform how life science companies operate both today and in the future.
"We are only beginning to tap the potential for RPA and AI technologies to improve life science discovery, development, and industry operations. With a clear value prop and measurable near-term ROI, the adoption of RPA in the industry is expected to be rapid and straightforward," says Alan S. Louie, research director, IDC Health Insights Life Science R&D Strategies and Technologies.